INVITRO AND INVIVO EFFECTS OF SM-10661, A NEWLY SYNTHESIZED PLATELET-ACTIVATING FACTOR(PAF) ANTAGONIST

被引：7
|
作者：
MOROOKA, S [1 ]
KOMURO, Y [1 ]
ANDO, R [1 ]
UCHIDA, M [1 ]
机构：
[1] SUMITOMO PHARMACEUT CO LTD,RES LABS,KONOHANA KU,OSAKA 554,JAPAN
来源：
PROSTAGLANDINS | 1988年 / 35卷 / 05期
关键词：
D O I：
10.1016/0090-6980(88)90243-2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：840 / 840
页数：1
相关论文
共 50 条
  • [41] Molecular modeling on platelet-activating factor (PAF) and new proposed PAF antagonists
    DeSantAnna, CMR
    DeAlencastro, RB
    Fraga, CAM
    Barreiro, EJ
    Neto, JDD
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 1996, 60 (05) : 1069 - 1080
  • [42] Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases
    Bae, KA
    Longobardi, L
    Karasawa, K
    Malone, B
    Inoue, T
    Aoki, J
    Arai, H
    Inoue, K
    Lee, TC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (35) : 26704 - 26709
  • [43] ROLE OF PLATELET-ACTIVATING FACTOR (PAF) IN THE OVOIMPLANTATION IN THE RAT - EFFECT OF THE SPECIFIC PAF-ACETHER ANTAGONIST, BN 52021
    ACKER, G
    HECQUET, F
    ETIENNE, A
    BRAQUET, P
    MENCIAHUERTA, JM
    PROSTAGLANDINS, 1988, 35 (02): : 233 - 241
  • [44] RELEASE OF PLATELET-ACTIVATING FACTOR (PAF) AND ACCELERATED HEALING INDUCED BY A PAF ANTAGONIST IN AN ANIMAL-MODEL OF CHRONIC COLITIS
    WALLACE, JL
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1988, 66 (04) : 422 - 425
  • [45] Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF
    Chaithra, Vyala Hanumanthareddy
    Jacob, Shancy Petsel
    Lakshmikanth, Chikkamenahalli Lakshminarayana
    Sumanth, Mosale Seetharam
    Abhilasha, Kandahalli Venkataranganayaka
    Chen, Chu-Huang
    Thyagarajan, Anita
    Sahu, Ravi P.
    Travers, Jeffery Bryant
    McIntyre, Thomas M.
    Kemparaju, Kempaiah
    Marathe, Gopal Kedihithlu
    JOURNAL OF LIPID RESEARCH, 2018, 59 (11) : 2063 - 2074
  • [46] Platelet-activating factor (PAF) acts as an autocrine capacitation factor.
    O'Neill, C
    Wu, CJ
    Stojanov, T
    BIOLOGY OF REPRODUCTION, 2000, 62 : 217 - 218
  • [47] RELEASE OF NEWLY SYNTHESIZED PLATELET-ACTIVATING-FACTOR (PAF) FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES UNDER INVIVO CONDITIONS - CONTRIBUTION OF PAF-RELEASING FACTOR IN SERUM
    MIWA, M
    SUGATANI, J
    IKEMURA, T
    OKAMOTO, Y
    INO, M
    SAITO, K
    SUZUKI, Y
    MATSUMOTO, M
    JOURNAL OF IMMUNOLOGY, 1992, 148 (03): : 872 - 880
  • [48] INVIVO EFFECTS OF CETIRIZINE ON CUTANEOUS REACTIVITY AND EOSINOPHIL MIGRATION INDUCED BY PLATELET-ACTIVATING FACTOR (PAF-ACETHER) IN MAN
    FADEL, R
    DAVID, B
    HERPINRICHARD, N
    BORGNON, A
    RASSEMONT, R
    RIHOUX, JP
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (03) : 314 - 320
  • [49] BLEOMYCIN-INDUCED LUNG INJURY IN THE RAT - EFFECTS OF THE PLATELET-ACTIVATING FACTOR (PAF) RECEPTOR ANTAGONIST BN 52021 AND PLATELET DEPLETION
    EVANS, TW
    MCANULTY, RJ
    ROGERS, DF
    CHUNG, KF
    BARNES, PJ
    LAURENT, GJ
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1990, 85 : 65 - 69
  • [50] A SYNTHETIC PHOSPHOLIPID INHIBITOR OF PLATELET-ACTIVATING FACTOR (PAF) BIOSYNTHESIS
    ROBBINS, JC
    MACHOY, BH
    LAM, MH
    PONPIPOM, MM
    RUPPRECHT, KM
    SHEN, TY
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 1269 - 1269
12345